Drug Profile
Docosahexaenoic acid - Martek Biosciences
Alternative Names: ARASCO; DHA - Martek Biosciences; DHA GOLD; DHASCO; Formulaid; Life'sDHA; NeurominsLatest Information Update: 13 Jan 2022
Price :
$50
*
At a glance
- Originator Martek Biosciences
- Developer Martek Biosciences; National Institutes of Health (USA)
- Class Antihyperlipidaemics; Docosahexaenoic acids; Eye disorder therapies; Small molecules
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Nutrition disorders
- No development reported Alzheimer's disease
- Discontinued Breast cancer; Colorectal cancer; Hyperlipidaemia; Malignant melanoma